Summary
Seungin Yang is a biomedical entrepreneur and founder-CEO with nine years of leadership building medical biotechnology and cosmetics ventures, including SolPine and related subsidiaries. Trained in neuropharmacology and neuroscience (Yonsei University and Seoul National University), he has hands-on research experience across receptor biology, cancer metastasis, stroke mechanisms, genomics, and stem cell therapeutics from top Korean hospitals and research institutes. He has translated deep academic expertise into commercial initiatives spanning stem cell therapy, exosome-based therapeutics, cosmetic biotech, medical tourism, and M&A advisory for Korea’s med‑bio market. Known for championing exosomes as a next‑generation platform, he combines scientific conviction with deal‑making and strategic planning experience at firms like MARIAbiotech and Biogenics. He offers investor-facing consulting on Korean medical‑bio opportunities and has a track record of guiding early-stage commercialization from lab discovery to business development. An unusual strength is his blend of bench-level receptor and signaling work with ongoing CEO-level execution across cross-border partnerships and corporate strategy.
9 years of coding experience
1 year of employment as a software developer
Ph.D. Candidate(Seoul National University of Medical School), neuroscience. stroke (i NOS & NF-kB). stem cell, Ph.D. Candidate(Seoul National University of Medical School), neuroscience. stroke (i NOS & NF-kB). stem cell at 서울대학교
Animal phsiology, recepter purify, Animal phsiology, recepter purify at 고려대학교
medical science master degree (Yonsei University of Medical School), neuro-pharmacology. immediately early gene ,pip92, medical science master degree (Yonsei University of Medical School), neuro-pharmacology. immediately early gene ,pip92 at 연세대학교